To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

Brand S.; Degenhardt T.; Nyirjesy P.; Sobel J.; Handelsman C.; Person K.; Schotzinger R.; Tavakkol A.

首页> 外文期刊>American Journal of Obstetrics and Gynecology >To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

【24h】

To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

机译：评估VT-1161（一种有效的，高度选择性的真菌CYP51抑制剂）在治疗具有复发性阴道念珠菌病（RVVC）病史的女性中的疗效和安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《American Journal of Obstetrics and Gynecology》 |2016年第6期|共1页
作者
Brand S.; Degenhardt T.; Nyirjesy P.; Sobel J.; Handelsman C.; Person K.; Schotzinger R.; Tavakkol A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类妇产科学;
关键词

相似文献

外文文献
中文文献
专利

1. To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC) [J] . Brand S., Degenhardt T., Nyirjesy P., American Journal of Obstetrics and Gynecology . 2016,第6期

机译：评估VT-1161（一种有效的，高度选择性的真菌CYP51抑制剂）在治疗具有复发性阴道念珠菌病（RVVC）病史的女性中的疗效和安全性
2. New evidence on oral L. plantarum P17630 product in women with history of recurrent vulvovaginal candidiasis (RVVC): a randomized double-blind placebo-controlled study [J] . R. Vladareanu, D. Mihu, M. Mitran, European review for medical and pharmacological sciences. . 2018,第1期

机译：有复发性外阴念珠菌病（RVVC）病史的女性口服植物乳杆菌P17630产品的新证据：一项随机双盲安慰剂对照研究
3. Oteseconazole Fungal lanosterol 14 alpha-demethylase (CYP51) inhibitor Treatment of recurrent vulvovaginal candidiasis Treatment of onychomycosis [J] . Thakare R., Dasgupta A., Chopra S. Drugs of the Future . 2019,第11期

机译：OteSeConazole真菌Lanteroll 14α-脱甲基酶（CYP51）抑制剂治疗反复性外阴阴离子念珠菌治疗甲癣
4. The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme [O] . A. G. S. Warrilow, C. M. Hull, J. E. Parker, 2014

机译：临床候选者VT-1161是白色念珠菌CYP51的高效抑制剂但未能结合人的酶
5. The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme [O] . Hull, Claire 2014

机译：临床候选人VT-1161是白色念珠菌CYp51的高效抑制剂，但未能结合人体酶

To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

著录项

相似文献

相关主题

期刊订阅